Crossing the blood-brain barrier: advances in nanoparticle technology for drug delivery in neuro-oncology

AM Hersh, S Alomari, BM Tyler - International journal of molecular …, 2022 - mdpi.com
The blood-brain barrier (BBB) constitutes a microvascular network responsible for excluding
most drugs from the brain. Treatment of brain tumors is limited by the impermeability of the …

Engineered nanomaterials that exploit blood-brain barrier dysfunction for delivery to the brain

JR Wu, Y Hernandez, KF Miyasaki, EJ Kwon - Advanced drug delivery …, 2023 - Elsevier
The blood–brain barrier (BBB) is a highly regulated physical and functional boundary that
tightly controls the transport of materials between the blood and the brain. There is an …

Emerging strategies to fabricate polymeric nanocarriers for enhanced drug delivery across blood-brain barrier: An overview

YH Song, R De, KT Lee - Advances in Colloid and Interface Science, 2023 - Elsevier
Blood-brain barrier (BBB) serves as an essential interface between central nervous system
(CNS) and its periphery, allowing selective permeation of ions, gaseous molecules, and …

Nanotechnology: a contemporary therapeutic approach in combating infections from multidrug-resistant bacteria

B Brar, S Marwaha, AK Poonia, B Koul, S Kajla… - Archives of …, 2023 - Springer
In the 20th century, the discovery of antibiotics played an essential role in the fight against
infectious diseases, including meningitis, typhoid fever, pneumonia and Mycobacterium …

Current approaches to facilitate improved drug delivery to the central nervous system

M Markowicz-Piasecka, P Darłak, A Markiewicz… - European Journal of …, 2022 - Elsevier
Although many pharmaceuticals have therapeutic potentials for central nervous system
(CNS) diseases, few of these agents have been effectively administered. It is due to the fact …

Nanomedicine-based immunotherapy for alzheimer's disease

M Hoque, A Samanta, SSM Alam, TA Zughaibi… - Neuroscience & …, 2023 - Elsevier
Alzheimer's disease (AD) is the most prevalent neurodegenerative disease caused by the
deposition of amyloid β (Aβ) fibrils forming extracellular plaques and the development of …

Alzheimer's disease treatment: the search for a breakthrough

AB Reiss, D Muhieddine, B Jacob, M Mesbah… - Medicina, 2023 - mdpi.com
As the search for modalities to cure Alzheimer's disease (AD) has made slow progress,
research has now turned to innovative pathways involving neural and peripheral …

Local delivery strategies for peptides and proteins into the CNS: Status Quo, challenges, and future perspectives

W Yue, J Shen - Pharmaceuticals, 2023 - mdpi.com
Over the past decades, peptides and proteins have been increasingly important in the
treatment of various human diseases and conditions owing to their specificity, potency, and …

Drug delivery systems as a strategy to improve the efficacy of FDA-approved Alzheimer's drugs

D Nunes, JA Loureiro, MC Pereira - Pharmaceutics, 2022 - mdpi.com
Alzheimer's disease (AD) is the most common form of dementia, with a high impact
worldwide, accounting for more than 46 million cases. The continuous increase of AD …

The management of Parkinson's disease: An overview of the current advancements in drug delivery systems

DD Nakmode, CM Day, Y Song, S Garg - Pharmaceutics, 2023 - mdpi.com
Parkinson's disease (PD) has significantly affected a large proportion of the elderly
population worldwide. According to the World Health Organization, approximately 8.5 million …